Sara Bolivar-Wagers

发表

Cytolytic CD4+ and CD8+ Regulatory T-Cells and Implications for Developing Immunotherapies to Combat Graft-Versus-Host Disease

B. Blazar, Sujeong Jin, Sara Bolivar-Wagers, 2022, Frontiers in Immunology.

Regulatory T Cell Therapy of Graft-versus-Host Disease: Advances and Challenges

B. Blazar, M. Hefazi, Sara Bolivar-Wagers, 2021, International journal of molecular sciences.

Bispecific chimeric antigen receptors targeting the CD4 binding site and high-mannose Glycans of gp120 optimized for anti-human immunodeficiency virus potency and breadth with minimal immunogenicity.

D. Vargas-Inchaustegui, E. Berger, B. Dey, 2018, Cytotherapy.

Retinoic acid signaling acts as a rheostat to balance Treg function

S. Furlan, D. Munn, H. Chi, 2022, Cellular & Molecular Immunology.

Murine CAR19 Tregs suppress acute graft-versus-host disease and maintain graft-versus-tumor responses

J. Wagner, B. Blazar, Mark J. Osborn, 2022, JCI insight.

Distinct Regulatory and Effector T Cell Metabolic Demands during Graft-Versus-Host Disease.

B. Blazar, K. Hippen, S. Rhee, 2019, Trends in immunology.

Evaluation of chimeric antigen receptor T cell therapy in non-human primates infected with SHIV or SIV

M. Roederer, G. Pavlakis, E. Berger, 2021, PloS one.

Immunodeficiency-related vaccine-derived poliovirus (iVDPV) cases: a systematic review and implications for polio eradication.

M. Holubar, Y. Maldonado, Sara Bolivar-Wagers, 2015, Vaccine.

Human CD19-specific switchable CAR T-cells are efficacious as constitutively active CAR T-cells but cause less morbidity in a mouse model of human CD19+ malignancy

Y. Refaeli, B. Blazar, Mark J. Osborn, 2022, Journal for ImmunoTherapy of Cancer.

Prevention of acute GVHD disease using an orthogonal IL-2/IL-2Rβ system to selectively expand regulatory T-cells in vivo.

J. Tolar, C. Eide, R. Negrin, 2022, Blood.